Erratum: An evidence-based protocol for smoking cessation for persons with psychotic disorders (Journal of Addictions Nursing (2010) 21 :2-3 (79-86) (DOI: 10.3109/10884602.2010.481505);An evidence-based protocol for smoking cessation for persons with psychotic disorders

Journal of Addictions Nursing

Volumn 21, Issue 2-3, 2010, Pages 79-86

  Morrison, Kim N ^a   Naegle, Madeline A ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Addiction; Co occurring Disorders; Contingency Management; Evidence based Practice; Motivational Interviewing; Nicotine Dependence; Protocol; Smoking Cessation

Indexed keywords

EID: 77953898223     PISSN: 10884602     EISSN: 15487148     Source Type: Journal    
DOI: 10.3109/10884602.2010.535741     Document Type: Erratum

References (27)

1. Baker, A., Richmond, R., Haile, M., Lewin, T.J., Hons, B., Vaughan, J.C. et al. (2006). A randomized controlled trial of smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry, 163, 1934-1942.
2. Chou, K.R., Chen, R., Lee, J.F., Ku, C.H., & Lu, R.B. (2004). The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. International Journal of Nursing Studies, 41, 321-330.
3. Cleveland Clinic Center. (2005). Diabetes and smoking: Another reason to quit. Retrieved April 8, 2008 from http://www.clevelandclinic.org/health/ heatlhinfo
4. de Leon, J. & Diaz, F. (2005). A meta-anaylsis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76, 135-157.
5. Department of Health and Human Services. (2007). Adult Cigarette Smoking in the United States: Current Estimates. Retrieved October 28, 2007, from http://www.cdc.gov/tobacco/data statistics/Factsheets/adult cig smoking.htm
6. DiClemente, C.C., Prochaska, J.O., Fairhurst, S.K., Velicer, W.F., Valasquez, M.M., & Rossi, J.S. (1991) The process of smoking cessation: An analysis of precontemplation, contemplation, and preparation stages of change. Journal of Consulting and Clinical Psychology, 59(2), 295-304.
7. El-Guebaly, N., Cathart, J.,Currie, S., Brown, D., & Gloster, S. (2002). Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatric Services, 53, 1166-1170.
8. Evins, A.E., Cather, C., Culhane, M.A., Birnbaum, A., Horowitz, J., Hsieh, E. et al. (2007). A12week double-blind, placebo-controlled study of buproprion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmocology, 27(4), 380-386.
9. Evins, A.E., Cather, C., Deckersbach, T., Freudenreich, O., Culhane, M.A., Olm-Shipman, C.M. et al. (2005). A double-blind, placebo-controlled trial of buproprion for smoking cessation in schizophrenia. Journal of Clinical Psychopharmocology, 25(3), 218-225.
10. Fiore, M.C., Baily, W.C., Cohen, S.J., Dorfman, S.F., Goldstein, M.G., Gritz, E.R. et al. (2000). Treating tobacco use and dependence. Clinical practice guidelines. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service.
11. Gallagher, S.M., Penn, P.E., Schindler, E., & Layne, W. (2007). A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. Journal of Psychoactive Drugs, 39(4), 487-497.
12. George, T., Vessicchio, J.C., Termine, A., Bregartner, T.A., Feingold, A., Rounsaville, B.J. et al. (2002).Aplacebo controlled trial of buproprion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53-61.
13. George, T., Ziedonis, D.M., Feingold, A., Pepper, W.T., Satterburg, C.A., Winkel, J. et al. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835-1842.
14. Hughes, J. (1993). Possible effects of smoke-free inpatient units on psychiatric diagnosis and treatment. Journal of Clinical Psychiatry, 54, 109-114.
15. Jaen, C., Stange, K., Tumiel, L., & Nutting, P. (1997). Missed opportunities for prevention: Smoking cessation advice and the competing demands of practice. Journal of Family Practic, 45(4), 348-354.
16. Lasser, K., Wesley, B.J, Wollhandler, S, Himmelstein, D.U., McCormick, D., & Bor, D.H. (2000). Smoking and mental illness: A population-based prevalence study. The Journal of the American Medical Association, 284(20), 2606-2610.
17. Macleod, Z.R., Charles, M.A., Arnaldi, V.C., & Adams, I.M. (2003). Telephone counseling as an adjunct to nicotine patches in smoking cessation: A randomized controlled trial. Medical Journal of Australia, 179, 349-352.
18. New York City Department of Health and Mental Hygiene (2008). What is mental illness? Retrieved August 8, 2008, from http://www.nyc.gov
19. Nides, M., Oncken, C., Gonzales, D., Rennard, S., Watsky, E.J., Anziano, R. et al. (2006) Smoking cessation with varenicline, a selective alpha 4 beta 2 nicotinic receptor partial agonist:Results from a 7-week, randomized, placebo and buproprion-controlled trial with 1-year follow-up. Archives of Internal Medicine, 166, 1561-1568.
20. Prochaska, J.J., & Goldstein, M. (1991). Process of smoking cessation: Implications for clinicians. Clinics in Chest Medicine, 12, 727-735.
21. Prochaska, J.J., Leek, D.M., Hall, S.E., & Hall, S.M. (2007). Cognitive interviews for measurement evaluation of the Fagerstr̈om Test for Nicotine Dependence (FTND) in smokers with schizophrenia spectrum disorders. Addictive Behaviors 32, 793-802.
22. Ranney, L., Melvin, C., Lux, L., McClain, E., & Lohr, K.N. (2006). Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Annals of Internal Medicine, 145, 845-856.
23. Stapleton, J.A., Watson, L., Spirling, L.I., Smith, R., Milbrandt, A., Ratcliffe, M. et al. (2007). Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction, 103, 146-154.
24. Steinberg, M.L., Ziedonis, D.M., Krejci, J.A., & Brandon, T.H. (2004). Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psycology, 72, 723-728.
25. Stetler, C. B., et al. (1998). Utilization-focused integrative reviews in a nursing service. Applied Nursing Research, 11(4), 195-206.
26. Weinberger, A.H., Reutenauer, E.L., Allen, T.M., Termine, A., Vessicchio, J.C. Sacco, K.A. et al. (2007). Reliability of the Fagerstrom test for nicotine dependence, Minnesota nicotine withdrawal scale, and Tiffany questionnaire for smoking urges in smokers with and without schizophrenia. Drug and Alcohol Dependence, 86, 278-282.
27. Ziedonis, D., Kosten, T., Glazer, W., & Frances, R. (1994). Nicotine dependence and schizophrenia. Hospital and Community Psychiatry, 45(3), 204-206